Bradycardia: Clinical Trials

14 trials for Bradycardia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Bradycardia: new trials by email Literature Review of Bradycardia trials Research Report on Bradycardia

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
Hyoscine Butylbromide 20 Mg/mL Solution for Injection Ampoule, Normal saline - Bradycardia, Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
Phase 4CompletedAssiut University1732019-10-102020-03-03
Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients
normal saline, atropine 0.5mg, ephedrine 8mg - Anesthesia, Spinal, Dexmedetomidine
Phase 4CompletedAjou University School of Medicine1022019-06-252021-02-04
Cardiac Rehabilitation After Pacemaker Implantation
cardiac rehabilitation - Bradycardia, Pacemaker
Phase 4CompletedPusan National University Hospital272018-04-102021-08-20
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
Sugammadex 2 mg/kg, Sugammadex 4 mg/kg, Sugammadex 16 mg/kg - Reversal of Neuromuscular Blockade
Phase 4CompletedMerck Sharp & Dohme LLC3442017-12-202020-10-08
Anticholinergic Premedication for Sedation With Dexmedetomidine During Spinal Anesthesia
Atropine, Dexmedetomidine, Ephedrine - Bradycardia
Phase 4CompletedSira Bang1202015-08-012016-01-18
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
Atropine - Bradycardia, Arrhythmias
Phase 4CompletedState University of New York at Buffalo602013-02-012023-04-06
0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant
Atropine 0.6 mg, Atropine 1.2 mg - Bradycardia, Neostigmine Adverse Reaction
Phase 4CompletedMahidol University402012-03-012014-07-10
Falls and Cardiovascular Events in Pacemaker Patients
Fill out Questionnaire - Bradycardia
Phase 4CompletedMedtronic Cardiac Rhythm and Heart Failure872009-08-012025-07-03
Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing
pacemaker implantation - Atrial Fibrillation, Bradycardia
Phase 4CompletedAbbott Medical Devices2042006-12-012019-02-04
Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response
Closed Loop Stimulation (CLS), Standard Rate Adaptive (R) Technology, Non-rate adaptive (DDD) pacing - Bradycardia
Phase 4CompletedBiotronik, Inc.14912006-05-012012-12-20
ULTRA Study for Pacemaker Patients
Pacemaker with Automatic Capture - Bradycardia
Phase 4CompletedBoston Scientific Corporation9502005-07-012007-07-10
Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
Atropine, Placebo - Arrhythmia, Respiratory Arrest
Phase 4CompletedMedical University of Vienna312003-10-012008-01-25
Austria Study - Analysis of Difference Between Active and Passive Fixation Leads
Flextend II, Fineline 2, Fineline Atrial J, Selute Picotip - Bradycardia, Heart Block
Phase 4CompletedGuidant Corporation1202003-09-012015-03-17
LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients
sensor programming - Bradycardia
Phase 4CompletedBoston Scientific Corporation15002003-07-012017-05-18

Narrower conditions

Arrhythmias, Cardiac (3)  ·  Sick Sinus Syndrome (2)  ·  Tachycardia (2)  ·  Apnea (1)  ·  Atrial Fibrillation (1)  ·  Carcinoma, Hepatocellular (1)  ·  Fractures, Bone (1)  ·  Heart Block (1)

Broader conditions

Cardiovascular Diseases (14)  ·  Heart Diseases (14)  ·  Pathologic Processes (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Arrhythmias, Cardiac (11)  ·  Cardiac Conduction System Disease (4)  ·  Arrhythmia, Sinus (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Heart Block (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)

Interventions

Atropine (5)  ·  Ephedrine (2)  ·  Saline Solution (2)  ·  Butylscopolammonium Bromide (1)  ·  Cardiac Rehabilitation (1)  ·  Dexmedetomidine (1)  ·  Glycopyrrolate (1)  ·  Neostigmine (1)  ·  Rocuronium (1)  ·  Solutions (1)  ·  Sugammadex (1)  ·  Vecuronium Bromide (1)

Sponsors

Boston Scientific Corporation (2)  ·  Abbott Medical Devices (1)  ·  Ajou University School of Medicine (1)  ·  Assiut University (1)  ·  Biotronik, Inc. (1)  ·  Guidant Corporation (1)  ·  Mahidol University (1)  ·  Medical University of Vienna (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Pusan National University Hospital (1)  ·  Sira Bang (1)  ·  State University of New York at Buffalo (1)

Countries

United States (4)  ·  Austria (3)  ·  South Korea (3)  ·  Germany (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Switzerland (1)

Top investigators

Arnulf Ferlitsch, MD (1)  ·  Bruce Koplan, MD (1)  ·  C Nimeth, MD (1)  ·  Christof Kolb, MD (1)  ·  Freddy Abi-Samra, MD (1)  ·  James Coman, MD (1)  ·  Jerrold Lerman, MD FRCPC (1)  ·  Michael Kuehne, Dr. med. (1)  ·  Ray Moser, PhD (1)  ·  Sira Bang, MD PhD (1)  ·  Sirilak Suksompong, MD (1)

Results publications

PMID 19018977, PMID 22745661, PMID 22858177, PMID 23419655, PMID 25762533, PMID 29908371, PMID 34711192, PMID 35448942

NIH funding

2017 (1)